Literature DB >> 8044215

The QALY--a measure of social value rather than individual utility?

E Nord1.   

Abstract

The paper examines different interpretations of the QALY concept. It is suggested that the QALY interpreted as a measure of amounts of well-life does not carry sufficient empirical meaning. As a measure of individuals' personal appreciation of outcomes in their own lives the QALY does not seem to work in comparisons of life saving interventions with interventions that improve health or increase life expectancy. For the QALY to be a generally empirically meaningful concept, it looks as though it needs to be interpreted as a measure of social value. This conclusion has direct implications for how values for health states should be elicited.

Mesh:

Year:  1994        PMID: 8044215     DOI: 10.1002/hec.4730030205

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  7 in total

1.  Public involvement in health care priority setting: an economic perspective.

Authors:  Tracy Roberts; Stirling Bryan; Chris Heginbotham; Alison McCallum
Journal:  Health Expect       Date:  1999-12       Impact factor: 3.377

2.  Resource allocation within Australian indigenous communities: a program for implementing vertical equity.

Authors:  V Wiseman; S Jan
Journal:  Health Care Anal       Date:  2000

3.  Vertical equity in health care resource allocation.

Authors:  G Mooney
Journal:  Health Care Anal       Date:  2000

4.  Efficient use of health care resources: the interaction between improved health and reduced health related income loss.

Authors:  Michael Hoel
Journal:  Int J Health Care Finance Econ       Date:  2002-11

5.  Mapping the Paediatric Quality of Life Inventory (PedsQL™) Generic Core Scales onto the Child Health Utility Index-9 Dimension (CHU-9D) Score for Economic Evaluation in Children.

Authors:  Tosin Lambe; Emma Frew; Natalie J Ives; Rebecca L Woolley; Carole Cummins; Elizabeth A Brettell; Emma N Barsoum; Nicholas J A Webb
Journal:  Pharmacoeconomics       Date:  2018-04       Impact factor: 4.981

6.  Cost-utility analysis: current methodological issues and future perspectives.

Authors:  Mark J C Nuijten; Dominique J Dubois
Journal:  Front Pharmacol       Date:  2011-06-08       Impact factor: 5.810

7.  Trading people versus trading time: what is the difference?

Authors:  Laura J Damschroder; Todd R Roberts; Christine C Goldstein; Molly E Miklosovic; Peter A Ubel
Journal:  Popul Health Metr       Date:  2005-11-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.